Skip to main content

Lantheus Holdings, Inc 8-K, filed Nov 10, 2026

Lantheus Holdings, Inc. (LNTH)

8-K 2026-11-10 For: 2026-11-08
View Original
Added on November 10, 2026

About this 8-K

Lantheus Holdings, Inc filed this 8-K on November 10, 2026, reporting on events of November 8, 2026.

On November 8, 2026, Lantheus Holdings, Inc. entered into a definitive agreement to sell its CDMO business and Springfield, New Jersey manufacturing facility to PharmaLogic, subject to customary closing conditions. Agilera will also manufacture lutetium Lu 177 dotatate for the company. AI summary

Items reported

  • Item 8.01: Other events